Changing Spectrum of Hemoptysis. Underlying Causes in 148 Patients Undergoing Diagnostic Flexible Fiberoptic Bronchoscopy
Overview
Authors
Affiliations
A retrospective study to examine the underlying causes of hemoptysis in patients undergoing diagnostic bronchoscopy was conducted. We found hemoptysis to be caused by bronchitis in 55 (37%) of 148, bronchogenic carcinoma in 28 (19%) of 148, tuberculosis in 10 (7%) of 148, and bronchiectasis in 1 (1%) of 148 patients. Compared with previous studies, it appears that hemoptysis is less likely to be caused by bronchiectasis or tuberculosis while hemoptysis caused by bronchitis has increased proportionately. The rate of occurrence of hemoptysis caused by bronchogenic carcinoma has not changed significantly. All patients with underlying bronchogenic carcinoma had a positive smoking history and abnormal chest roentgenogram. The rate of hemoptysis was not a good indicator of the underlying disease.
Treatment of Massive Hemoptysis with Repeated Doses of Nebulized Tranexamic Acid.
Cutshall D, Inman B, Myers M Cureus. 2022; 14(9):e29625.
PMID: 36321025 PMC: 9605738. DOI: 10.7759/cureus.29625.
Management of life-threatening hemoptysis in the ICU.
Charya A, Holden V, Pickering E J Thorac Dis. 2021; 13(8):5139-5158.
PMID: 34527355 PMC: 8411133. DOI: 10.21037/jtd-19-3991.
Eltahir M, Elshafei M, Elzouki A Eur J Case Rep Intern Med. 2021; 7(12):001930.
PMID: 33585326 PMC: 7875595. DOI: 10.12890/2020_001930.
Angileri S, Roda G, Arrichiello A, Signorelli G, Di Meglio L, Gurgitano M Acta Biomed. 2020; 91(10-S):e2020009.
PMID: 33245068 PMC: 8023073. DOI: 10.23750/abm.v91i10-S.10265.
Management of life-threatening hemoptysis.
Kathuria H, Hollingsworth H, Vilvendhan R, Reardon C J Intensive Care. 2020; 8:23.
PMID: 32280479 PMC: 7132983. DOI: 10.1186/s40560-020-00441-8.